YD Bio (NASDAQ:YDES) Shares Up 5% – Still a Buy?

Shares of YD Bio Limited (NASDAQ:YDES) traded up 5% during trading on Tuesday. The company traded as high as $7.56 and last traded at $7.4650. Approximately 150,311 shares changed hands during trading, an increase of 7% from the average daily volume of 140,894 shares. The stock had previously closed at $7.11.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded shares of YD Bio to a “hold” rating in a report on Saturday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

YD Bio Stock Up 3.6%

The firm’s fifty day moving average price is $3.42 and its 200 day moving average price is $4.16.

YD Bio (NASDAQ:YDES) last released its quarterly earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 EPS for the quarter. The firm had revenue of $0.42 million for the quarter.

Hedge Funds Weigh In On YD Bio

A hedge fund recently raised its position in YD Bio stock. Cypress Capital Management LLC WY grew its holdings in shares of YD Bio Limited (NASDAQ:YDES) by 9.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,690 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the period. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 as of its most recent SEC filing.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.